Latest News in the pharma Industry

All

Partnership formed to develop and commercialise ready-to-use medicine

Partnership formed to develop and commercialise ready-to-use medicine

13 Jan 2020

The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products.

Read more 
Lupin could face FDA regulatory action over Tarapur API facility

Lupin could face FDA regulatory action over Tarapur API facility

13 Jan 2020

India’s Lupin Pharmaceuticals warned Monday it could face regulatory sanctions from the US Food and Drug Administration over its Tarapur active pharmaceutical ingredient (API) manufacturing facility.

Read more 
VAV Lipids to exhibit in CPhI 2020 in Milan, Italy

VAV Lipids to exhibit in CPhI 2020 in Milan, Italy

10 Jan 2020

VAV lipids will exhibit at CPhI Worldwide in Milan , the world's largest pharmaceutical networking event.

Read more 
Dr. Mark Bittinger joins Sai Life Sciences as Global Head of Biology

Dr. Mark Bittinger joins Sai Life Sciences as Global Head of Biology

10 Jan 2020

Dr. Mark Bittinger has joined Sai Life Sciences as Vice President and Global Head of Biology. Mark will be based out of companys' new Discovery Biology facility in Cambridge, Massachusetts, USA, which provides exploratory biology capabilities to the...

Read more 
Jay Stella joins Sai Life Sciences as Chief Business Officer

Jay Stella joins Sai Life Sciences as Chief Business Officer

10 Jan 2020

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for t...

Read more 
CPhI and AAPS partner to expand expert scientific content at CPhI North America

CPhI and AAPS partner to expand expert scientific content at CPhI North America

10 Jan 2020

CPhI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPhI, including CPhI North America—the only event to bring the entire North American pharmac...

Read more 
ReadCoor to commercially launch spatial sequencing platform

ReadCoor to commercially launch spatial sequencing platform

10 Jan 2020

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine.

Read more 
Mylan recalls batches of Nizatidine capsules after nitrosamine detected in API

Mylan recalls batches of Nizatidine capsules after nitrosamine detected in API

9 Jan 2020

The US arm of generic and specialty pharma company Mylan Pharmaceuticals has recalled three lots of its heartburn drug Nizatidine in capsule form amid fears of possible nitrosamine contamination.

Read more 
BONA Service: Spray performance analysis per FDA guidance

BONA Service: Spray performance analysis per FDA guidance

8 Jan 2020

Includes:
* Spray pattern
* Plume geometry
* Droplet size distribution

Other tests:
* Priming and Repriming
* Dosage
* Dose uniformity

Read more 
New HQ for developer of world's first fully automated drug discovery platform

New HQ for developer of world's first fully automated drug discovery platform

8 Jan 2020

End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data.

Read more 
VAV Life Sciences launches India’s first phospholipid manufacturing plant

VAV Life Sciences launches India’s first phospholipid manufacturing plant

7 Jan 2020

VAV Life Sciences has inaugurated its cGMP compliant phospholipid manufacturing plant in Mirjole, Ratnagiri, Maharashtra.

Read more 
Catalent completes purchase of biologics fill-finish and oral solid dose facility

Catalent completes purchase of biologics fill-finish and oral solid dose facility

7 Jan 2020

Facility provides European customers with great biologics and oral dose capabilities that can help reduce time-to-market.

Read more